Hostname: page-component-586b7cd67f-rdxmf Total loading time: 0 Render date: 2024-11-27T00:02:38.654Z Has data issue: false hasContentIssue false

You can't pay me to quit: the failure of financial incentives for smoking cessation in head and neck cancer patients

Published online by Cambridge University Press:  15 February 2016

A Ghosh*
Affiliation:
Department of Otorhinolaryngology: Head and Neck Surgery, University of Pennsylvania, Philadelphia, USA
G Philiponis
Affiliation:
Department of Otorhinolaryngology: Head and Neck Surgery, University of Pennsylvania, Philadelphia, USA
A Bewley
Affiliation:
Department of Otorhinolaryngology, University of California, Davis, USA
E R Ransom
Affiliation:
Center for Facial Plastic, Reconstructive, and Laser Surgery, San Francisco, California, USA
N Mirza
Affiliation:
Department of Otorhinolaryngology: Head and Neck Surgery, University of Pennsylvania, Philadelphia, USA
*
Address for correspondence: Dr Ankona Ghosh, Department of Otorhinolaryngology: Head and Neck Surgery, University of Pennsylvania, 3400 Spruce Street, 5 Ravdin, Philadelphia, PA 19104, USA E-mail: [email protected]

Abstract

Objective:

A prospective randomised study was conducted at a tertiary care hospital to evaluate the effects of financial incentives for smoking cessation targeted at a high-risk population.

Methods:

Patients with a past history of head and neck cancer were voluntarily enrolled over a two-year period. They were randomised to a cash incentives or no incentive group. Subjects were offered enrolment in smoking cessation courses. Smoking by-product levels were assessed at 30 days, 3 months and 6 months. Subjects in the incentive group received $150 if smoking cessation was confirmed.

Results:

Over 2 years, 114 patients with an established diagnosis of head and neck cancer were offered enrolment. Twenty-four enrolled and 14 attended the smoking cessation classes. Only two successfully quit smoking at six months. Both these patients were in the financially incentivised group and received $150 at each test visit.

Conclusion:

Providing a financial incentive for smoking cessation to a population already carrying a diagnosis of head and neck cancer in order to promote a positive behaviour change was unsuccessful.

Type
Main Articles
Copyright
Copyright © JLO (1984) Limited 2016 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

Presented at the Combined Otolaryngology Spring Meetings, 10–14 April 2013, Orlando, Florida, USA.

References

1Centers for Disease Control and Prevention (CDC). Smoking-attributable mortality, years of potential life lost, and productivity losses–United States, 2000–2004. MMWR Morb Mortal Wkly Rep 2008;57:1226–8Google Scholar
2Bray, RM, Hourani, LL, Olmstead, KL, Witt, M, Brown, JM, Pemberton, MR et al. 2005 Department of Defense Survey of Health Related Behaviors Among Active Duty Military Personnel. A Component of the Defense Lifestyle Assessment Program (DLAP). Research Triangle Park, North Carolina: RTI International, 2006Google Scholar
3McKinney, WP, McIntire, WD, Carmody, TJ. Comparing the smoking behavior of veterans and nonveterans. Public Health Rep 1997;112:212–17, discussion 218Google ScholarPubMed
4Negri, E, La Vecchia, C, Franceschi, S, Tavani, A. Attributable risk for oral cancer in northern Italy. Cancer Epidemiol Biomarkers Prev 1993;2:189–93Google ScholarPubMed
5Schwartz, LH, Ozsahin, M, Zhang, GN. Synchronous and metachronous head and neck carcinomas. Cancer 1994;74:1933–83.0.CO;2-X>CrossRefGoogle ScholarPubMed
6Lee, JM, Turini, M, Botteman, MF, Stephens, JM, Pashos, CL. Economic burden of head and neck cancer. A literature review. Eur J Health Econ 2004;5:7080CrossRefGoogle ScholarPubMed
7Kahende, JW, Loomis, BR, Adhikari, B, Marshall, L. A review of economic evaluations of tobacco control programs. Int J Environ Res Public Health 2009;6:5168CrossRefGoogle ScholarPubMed
8Volpp, KG, Gurmankin, L A, Asch, DA, Berlin, JA, Murphy, JJ, Gomez, A et al. A randomized controlled trial of financial incentives for smoking cessation. Cancer Epidemiol Biomarkers Prev 2006;15:1218CrossRefGoogle ScholarPubMed
9Volpp, KG, Troxel, AB, Pauly, MV, Glick, HA, Puig, A, Asch, DA et al. A randomized, controlled trial of financial incentives for smoking cessation. N Engl J Med 2009;360:699709CrossRefGoogle ScholarPubMed
10Moores, LK. Smoking and postoperative pulmonary complications. An evidence-based review of the recent literature. Clin Chest Med 2000;21:139–46, ix–xCrossRefGoogle ScholarPubMed
11Schwartz, JL. Review and Evaluation of Smoking Cessation Methods; The United States and Canada 1975–1987, Publication no. 79-8369. Washington: Government Printing Office, 1987Google Scholar
12Lee, B, Volpp, K. Potential cost savings from smoking cessation in the Veterans Affairs patient population. Abstr Academy Health Meet 2004;21:abstract no. 1648Google Scholar
13Cahill, K, Perera, R. Competitions and incentives for smoking cessation. Cochrane Database Syst Rev 2011;(4):CD004307CrossRefGoogle Scholar